Mirae Asset Global Investments
INZY

Mirae Asset Global Investments’s Inozyme Pharma INZY Stock Holding History

Mirae Asset Global Investments’s Portfolio INZY Stock Details INZY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-2,494
Closed -$9.98K – 1672
2025
Q2 		$9.98K Buy
2,494
+440
+21% +$1.09K ﹤0.01% 1492
2025
Q1 		$1.89K Sell
2,054
-87
-4% -$121 ﹤0.01% 1540
2024
Q4 		$6.25K Buy
+2,141
New +$8.14K ﹤0.01% 1541
2023
Q4 		– Sell
-55,403
Closed -$233K – 2571
2023
Q3 		$233K Hold
55,403
– – ﹤0.01% 2242
2023
Q2 		$309K Buy
+55,403
New +$327K ﹤0.01% 2172

Mirae Asset Global Investments's INZY Position: Q3 2025 in Review

Mirae Asset Global Investments sold out of Inozyme Pharma (INZY) in Q3 2025, closing a stake of 2,494 shares — an estimated $9.98K sold.

Mirae Asset Global Investments first reported a position in INZY in Q2 2023 and held it in 5 quarters. The position peaked at $309K in Q2 2023. 0 funds tracked by Wall St. Rank hold INZY as of Q3 2025.

  • Mirae Asset Global Investments reported no remaining Inozyme Pharma position as of Q3 2025 after selling out during the quarter.
  • Mirae Asset Global Investments sold 2,494 Inozyme Pharma shares in Q3 2025, an estimated $9.98K.
  • Mirae Asset Global Investments first reported a position in Inozyme Pharma in Q2 2023 and held it in 5 quarters.
  • Mirae Asset Global Investments's Inozyme Pharma position peaked at $309K in Q2 2023.
  • 0 funds tracked by Wall St. Rank held Inozyme Pharma as of Q3 2025.

Based on Mirae Asset Global Investments's 13F filing for Q3 2025, filed 3 Nov 2025.